|
WO2016101885A1
|
|
Necrosis inhibitors
|
|
WO2015161824A2
|
|
Sesquiterpenoids
|
|
WO2015158241A1
|
|
Reg3 therapeutics
|
|
CN106660972A
|
|
5-HT2B antagonists
|
|
CN105085366A
|
|
Indole skeleton compound and application thereof
|
|
CN103845317A
|
|
Application of entacapone to prevention or treatment of obesity and other metabolic syndrome
|
|
WO2013159243A1
|
|
Compositions and uses of functional receptor for hbv/hdv virus
|
|
CN102516384A
|
|
MLKL protein and application of MLKL protein as target point of cell necrosis inhibitor
|
|
CN102911948A
|
|
Method for detecting enterovirus neutralizing antibody and special recombinant virus for method
|
|
CN102250753A
|
|
Device for drawing deoxyribonucleic acid (DNA) molecule into line shape and application thereof
|
|
CN101705210A
|
|
Anti-melamine monoclonal antibody and application thereof
|
|
CN101717444A
|
|
Kit for detecting melamine and application thereof
|
|
CN102079728A
|
|
Tripolycyanamide analogue, preparation method of tripolycyanamide analogue and intermediate used in preparation method
|
|
CN101173271A
|
|
Method for deactivation of mitogen activation protein kinase
|
